Intersect ENT, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2018 and for the first quarter and full year of fiscal 2019. Preliminary unaudited revenue for the full year 2018 is expected to be in the range of $108.3 to $108.5 million, an increase of 12-13% compared to $96.3 million for 2017. Preliminary unaudited revenue for the fourth quarter of 2018 is expected to be in the range of $32.6 to $32.8 million, an increase of 11% compared to $29.5 million for the fourth quarter of 2017. The company forecasts full year 2019 revenue in the range of $123 to $127 million and first quarter 2019 revenue in the range of $26.0 to $26.5 million.